Research
Energy balance
Glucagon coagonists like survodutide and mazdutide have demonstrated significant weight loss and improved glycemic control.
These agents may be effective options for patients needing weight loss and glycemic control.
StrongSupportsmedium confidence
Glucagon coagonists like survodutide and mazdutide have demonstrated significant weight loss and improved glycemic control.
Why this rating
The abstract provides direct claims about the efficacy of these agents.
Source
Novel GLP-1-based Medications for Type 2 Diabetes and Obesity
Jang Won Son et al. · Endocrine Reviews · 2025
reviewCited 17×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →